Nutrition, Healthy
Conditions
Brief summary
This is a prospective, 2-group crossover, randomized, double-blind study to evaluate nutrient absorption.
Interventions
Consumed on white bread
Consumed on white bread
Sponsors
Study design
Eligibility
Inclusion criteria
* Adult participants (18-55 years of age) * Body mass index (BMI) \<30 kg/m2 * Males and nonpregnant, nonlactating females * Free of gastrointestinal disorders that my impact nutrient absorption in the small intestine, endocrine, hepatic, renal, or bone diseases
Exclusion criteria
* Use of vitamin D or calcium supplements within 3 weeks prior to the Screening Visit. * Use of a tanning booth/lamp within 3 weeks prior to the Screening Visit. * Travel to sunny location within 3 weeks prior to the Screening Visit. * Consumption of more than 3 alcoholic drinks per day starting 48 hours before the Screening Visit. * Has an allergy or intolerance to any ingredient in the study product. * Participating in another study that has not been approved as a concomitant study by Abbott Nutrition. * Use of the following medications that may have interactions with vitamin D absorption or metabolism: * Aluminum-containing phosphate binders * Anticonvulsants * Atorvastatin * Calcipotriene * Cholestyramine * Cytochrome P-450 3A4 substrates * Digoxin * Diltiazem * Orlistat * Thiazide diuretics * Corticosteroids * Stimulant laxatives * Verapamil
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Vitamin D Absorption | Time 0 to 24 Hours | Change in area under the curve (AUC) of serum vitamin D for low dose in experimental versus control oil |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Vitamin D Absorption - Peak | Time 0 to 48 Hours | Change in Peak serum for vitamin D in experimental versus control oil |
| Vitamin D Absorption - AUC | Time 0 to 48 Hours | Change in AUC for vitamin D in experimental versus control oil |
Other
| Measure | Time frame | Description |
|---|---|---|
| Body Mass Index | Visit 1, Baseline Collection | As calculated from height in cm and weight in kg |
| Adverse Events | Study Day 1 to Study Day 7 up to 20 Days | Participant reported adverse events during study duration |
Countries
United States